Spyre Therapeutics Inc (SYRE)

Cash Ratio

2.56

Quarterly · Period ending:

SYRE logo

SYRE Cash Ratio

Latest reported2.56
SYRE Quarterly Cash Ratio (0.00 → 2.56)
High-resolution chart · PNG

SYRE cash ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Cash Ratio — Quarterly
Period endingCash Ratio
2.5593
1.1412
1.4607
1.4025
0.9831
0.6861
1.6541
1.244
2.0407
5.3144
5.907
2.0189
1.0135
2.7889
2.3788
2.2055
2.3622
0.8981
0.7517
1.2074
1.6873
2.4786
5.4792
3.7789
4.1355
0.7349
1.0487
1.5942
1.9533
7.2544
2.1937
1.9337
3.3326
1.8664
2.277
2.6988
6.0964
4.2459
12.0424
12.9122
21.014
6.2869
11.6108
12.7491
14.4691
36.8611
2.4726
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.